Dietary Supplements

07
Apr
How Does This Stuff Continue to Happen?

How Does This Stuff Continue to Happen?

Today, the FDA issued yet another health warning regarding an unapproved sexual enhancement product marketed as an over-the-counter drug and, boy, is this one a doozy.  It contains sildenafil and tadalafil, the active ingredients in approved Viagra and Cialis, while also containing, flibanserin, which “is the active ingredient in Addyi, an FDA-approved prescription drug used […]

Read More
03
Feb
Dietary Supplements that Contain Undeclared Drug Ingredients - Lachman Blog

FDA Issues Warning About Dietary Supplements that Contain Undeclared Drug Ingredients

Today, the FDA again advised consumers to avoid purchasing and using Umary, a product marketed as a dietary supplement to treat pain; it contains the undeclared prescription drug ingredients diclofenac and omeprazole. The Agency first warned consumers about this product and another, similar product marketed as Amazy in June 2024 and reissued that warning in […]

Read More
25
Sep
Health Fraud and Products with Undeclared Prescription or Dangerous Unapproved Ingredients - Lachman Blog

Health Fraud and Products with Undeclared Prescription or Dangerous Unapproved Ingredients

For those of you who regularly read our blog posts, we are often harping about dietary supplements that contain undeclared prescription drug ingredients or unapproved and potentially dangerous ingredients. While we only highlight some of the more egregious products that have received FDA attention, there are many, many more that we do not address. According […]

Read More
27
Aug
Attention!

FDA Warns About Unapproved Marketed Drug Product in Disguise

Earlier this week, the Agency issued a statement warning consumers not to use or purchase Pain Flex, sold as a dietary supplement for joint pain, as it contains undeclared dexamethasone and methocarbamol.  Both ingredients have the potential to cause significant serious adverse events in some users. The Agency says that dexamethasone is a “corticosteroid commonly […]

Read More
03
Jun
Do More with Less - Lachman Blog

Do More with Less – Looks Like That Is What the FDA Budget Request Asks

Now, here is a head scratcher. According to the Pink Sheet article written by Sue Sutter (here), “The White House requested $6.76bn, a decrease of 3.9%, or $271.5m, from the FY 2025 funding level. The proposal includes $3.17bn in budget authority, a decrease of 11.4%, and $3.59bn in user fees, a 4% increase.” What a dandy, […]

Read More
08
Oct

FDA Warns of Triple-Threat Product Marketed as Dietary Supplement

Well, there is bad, then there is worse!  In this case, the FDA warns us about a product that is being marketed as all natural and promoted as a dietary supplement for joint and muscle pain.  The product, called Trinity Gold, actually contains three undeclared drug ingredients, acetaminophen, diclofenac, and phenylbutazone (which was removed from […]

Read More
23
May
Roadside trailer with local produce for sale, Mendoza, Argentina.

Fraudulent Drugs: A Struggle That FDA Grapples with Every Day

We have written a lot about fraudulent drugs over the years.  Some examples of these include counterfeit drugs, dietary ingredients that are unsafe, dietary drugs that contain undeclared prescription drugs in them, and the list goes on and on.  In his presentation titled “Fraudulent Drugs: You’re Taking What?” (here), Brad Pace, Associate Director, Office of […]

Read More
1 2 4